retatrutide lawsuit Warning issued over counterfeit weight-loss drugs labelled as #Retatrutide Lawsuit

GLP-1R is represented as cartoon (cyan) with the ECD coloured brown

The faster you lose weight, and the more you lose, the more likely you are to notice facial changes

People who were more depleted to start often notice a difference faster than people who had adequate baseline levels

J., Cragg, G

These medications work by mimicking natural hormones that regulate appetite and blood sugar levels, helping patients achieve significant weight reduction when combined with lifestyle modifications

It took more than two years of intensive, capital-intensive manufacturing expansion for both companies to resolve those shortages: tirzepatide was removed from the FDA shortage list on December 19, 2024, semaglutide on February 21, 2025